Lv21
110 积分 2025-06-18 加入
Efficacy and safety of Efsubaglutide Alfa in “overrun” patients in the SUPER2 trial: A post‐hoc analysis for comprehensive evaluation
2天前
已关闭
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
2个月前
已完结
Developing, Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)
2个月前
已完结
Myostatin/activin pathway antagonism: Molecular basis and therapeutic potential
2个月前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
2个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
2个月前
已完结
Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999-2004
3个月前
已完结
Current pharmacotherapies for sarcopenia
3个月前
已完结
Sarcopenic obesity: definition, cause and consequences
3个月前
已完结
皖公网安备34019202002308
